SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinomaYu-Feng Yang(Dongguan People’s Hospital), Hong Yang(Sun Yat-sen University)Molecular CancerAugust 8, 201810.1186/s12943-018-0872-3Cited by 137SaveCiteExport RISWatch citationsRelated PapersStemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma|Oncotarget|2015|47miR-424 coordinates multilayered regulation of cell cycle progression to promote esophageal squamous cell carcinoma cell proliferation|EBioMedicine|2018|46PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma|Oncotarget|2017|45